D-1445-2020 Class III Terminated
FDA drug recall D-1445-2020 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Jul 6, 2020 and is designated Class III. Reason for recall: Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine The recall status is terminated (terminated Jun 8, 2023). Affected quantity: 3516 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 5, 2020
- Initiation Date
- Jul 6, 2020
- Termination Date
- Jun 8, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3516 bottles
Product description
Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, 60-count bottle, Rx only, Mfg by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 57664-783-86
Reason for recall
Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine
Distribution pattern
Nationwide USA
Code information
Lot #: AA84106, Exp 9/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1445-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026